Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Short-term Investments (2019 - 2022)

TransMedics (TMDX) has 4 years of Short-term Investments data on record, last reported at $27.7 million in Q2 2022.

  • For Q2 2022, Short-term Investments fell 68.14% year-over-year to $27.7 million; the TTM value through Jun 2022 reached $27.7 million, down 68.14%, while the annual FY2021 figure was $66.9 million, 33.83% down from the prior year.
  • Short-term Investments reached $27.7 million in Q2 2022 per TMDX's latest filing, down from $54.1 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $111.3 million in Q3 2020 and bottomed at $27.7 million in Q2 2022.
  • Average Short-term Investments over 4 years is $70.4 million, with a median of $67.4 million recorded in 2019.
  • Peak YoY movement for Short-term Investments: surged 91.12% in 2021, then crashed 68.14% in 2022.
  • A 4-year view of Short-term Investments shows it stood at $60.6 million in 2019, then soared by 66.78% to $101.1 million in 2020, then plummeted by 33.83% to $66.9 million in 2021, then crashed by 58.58% to $27.7 million in 2022.
  • Per Business Quant database, its latest 3 readings for Short-term Investments were $27.7 million in Q2 2022, $54.1 million in Q1 2022, and $66.9 million in Q4 2021.